Moderna's Non-clinical Summary for Spikevax - Evidence of Scientific and Regulatory Fraud
Hong Kong’s use of electronic tracking wristbands not ‘foolproof’ solution to deter Covid-19 patients from breaching quarantine, experts say
Hong Kong to electronically tag Covid patients as it adopts China’s health code system
Quote:Findings:
- Moderna's nonclinical summary contains mostly irrelevant materials.
- Moderna claims that the active substance mRNAs of Spikevax does not need to be studied for toxicity and can be replaced with any other mRNA without further testing.
- Moderna’s nonclinical program consisted of studies of other unapproved mRNAs and only one non-GLP toxicology study of mRNA-1273 (active substance of SPIKEVAX).
- There are two separate Investigational New Drug numbers for mRNA-1273: one held by Moderna, the other – by DMID (NIH), representing a serious conflict of interest.
- The vaccine-induced antibody-enhanced disease was identified as a serious risk and was not excluded by Moderna due to absence of positive control and unvalidated methods used.
- FDA and Moderna lied about reproductive toxicology studies in public disclosures and product labeling.
Hong Kong’s use of electronic tracking wristbands not ‘foolproof’ solution to deter Covid-19 patients from breaching quarantine, experts say
Hong Kong to electronically tag Covid patients as it adopts China’s health code system
Quote:Using electronic tracking wristbands to deter Covid-19 patients from breaching quarantine in Hong Kong is not a “foolproof” solution, IT and health experts have said.
A mainland Chinese-style three-colour system was also considered “fraught with loopholes” as patients could still access public transport and go to work, the experts added, as they called for a deeper rethink of Hong Kong’s Covid-19 policies with the rebound in infections.
The experts said strictly enforcing a seven-day home isolation for patients without proper government support could lead to unintended consequences.